Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Glicentin ELISA Kit (AC2934)
Cat.#: ASET-1523
Specifications
Description Human Glicentin ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human Glicentin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2195 Human PTPRS ELISA Kit (AC3606) Quantitative inquiry ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1846 Human HCN4 ELISA Kit (AC3257) Quantitative inquiry ASET-1712 Human GnRHR ELISA Kit (AC3123) Quantitative inquiry ASET-1932 Human ADAM17 ELISA Kit (AC3343) Quantitative inquiry ASET-1114 Rat Copeptin ELISA Kit (AC2525) Quantitative inquiry ASET-1064 Mouse TSH beta ELISA Kit (AC2475) Quantitative inquiry ASET-1242 Mouse Wnt6 ELISA Kit (AC2653) Quantitative inquiry ASET-1435 Monkey Heme Oxygenase 1 ELISA Kit (AC2846) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket